Cti Biopharma (CTIC) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cti Biopharma Corp   (NASDAQ: CTIC)


Cti Biopharma 's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Cti Biopharma 's ROA in the first quarter of 2023?
Cti Biopharma Corp recorded a cumulative net loss of $-69 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -55.85%.

However, within the Healthcare sector 782 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2023 quarter, so far to 4818, from total ROA ranking in the fourth quarter of 2022 at 5748.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Total Assets Change -14.58 % 73.43 % 21.97 % 73.6 % 207.17 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -69 -93 -112 -121 -118
Return On Assets (TTM) -55.85 % -72.22 % -97.28 % -109.91 % -123.18 %
CTIC's Total Ranking # 4818 # 5748 # 5257 # 5426 # 5410
Total Assets (TTM) in million 112 126 123 135 131
Seq. Total Assets Change -10.63 % 1.75 % -8.23 % 2.36 % 81.45 %
Seq. Net Income Change - - - - -

CTIC's 5 Years Annual ROA >> Back to CTIC Management Effectiveness >> Compare CTIC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 349
Sector # 783
Overall # 4718

Return On Assets Statistics
High Average Low
-20.59 %
-86.28 %
-211.43 %
(Sep 30 2014)   (Dec 31 2012)





Financial Statements
Cti Biopharma 's Assets $ 112 million CTIC's Balance sheet
Cti Biopharma 's Income $ -13 million Quarterly CTIC's Income Statement
CTIC's Income by Division See CTIC's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change 73.43 % 24.37 % 25.84 % -48.48 % 63.67 %
Total Assets in million 126 72 58 46 90
Y / Y Net Income Change - - - - -
Net Income in million -93 -98 -52 -40 -29
Annual Return On Assets -74.03 % -135.17 % -90.06 % -86.48 % -32.67 %

CTIC's 5 Years Annual ROA >> Back to CTIC Management Effectiveness >> Compare CTIC ROA to its Competitors



More Return On Assets Ratios
CTIC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CTIC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CTIC's Competitors
Subscribers only: Roa for Cti Biopharma 's Suppliers
Subscribers only: Return On Assets for CTIC's Customers

You may also want to know
CTIC's Roi CTIC's Inventory Turnover Ratio CTIC's Growth Rates CTIC's Dividend Comparisons
CTIC's Profitability Ratios CTIC's Asset Turnover Ratio CTIC's Dividend Growth
CTIC's Roe CTIC's Valuation Ratios CTIC's Financial Strength Ratios CTIC's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:58+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.